Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // March 5th, 2010 // 7:40 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Archimedes Pharma hired Jeff Buchalter as ceo and president. Most recently, he was ceo at Enzon Pharmaceuticals, which is in the process of revamping its strategy under pressure from Carl Icahn and Dellacamera Capital.
Mylan Labs appointed John Sheehan exec vp and cfo;
Urigen Pharmaceuticals named Ed Teitel as chairman;
Orexigen Therapeutics added Peter Honig to its board;
Aperio Technologies tapped Keith Hagen as chief operating officer;
Inspire Pharmaceuticals added George Abercrombie to its board;
Simcere Pharmaceutical hired Yehong Zhang as president;
Kinex Pharmaceuticals hired Rudolf Kwan as chief medical officer;
Sanofi-Aventis nominated Catherine Brechignac to its board;
Transdel Pharmaceuticals hired Terry Nida as chief business officer;
Zogenix hired Ann Rhoads as cfo;
Garnet BioTherapeutics hired Sanjay Batra as sr vp of development;
PharmaNet Development Group named George McMillan as cfo;
Catalyst Biosciences named William Dawson as cfo;
Regenesis Biomedical added Peter Sheehan to its board;
Cook Pharmica named Veda Walcott vp of quality and corporate compliance officer;
Ladder shot thx to Robert CB on Flickr Creative Commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Aperio Technologies, Archimedes Pharma, Catalyst Biosciences, Cook Pharmica, Garnet BioTherapeutics, Inspire Pharmaceuticals, Kinex Pharmaceuticals, Mylan Laboratories, Orexigen Therapeutics, PharmaNet Development Group, Regeneis Biomedical, Sanofi Aventis, Simcere Pharmaceuticals, Transdel Pharmaceuticals, Urigen Pharmaceuticals